Utility of Animal Models for Evaluating Preclinically Novel HBV Therapeutics
Time: 2:30 pm
day: Day One
Details:
• Why doesn’t HBV infect mice and how can the barrier be overcome?
• Analyze advances in development of (immunocompetent) humanized mice
• Discuss emerging NHP models for modeling chronic HBV
